We experimentally investigated the pathogenicity of clinically isolated
Enterococcus faecalis (
E. faecalis) in urinary tract of non-treated and diabetic mice. The results are summarized as follows.
(1)
In vitro, new pyridonecarbonic acids (CPFX, OFLX, ENX and NFLX) were most effective against 23 clinically isolated strains of
E. faecalis, followed by ST, MINO, ABPC and IPM/CS. Most of the isolates showed high resistance to cephems.
(2) In non-treated mice, ascending pyelonephritis occurred with 9 of 11
E. faecalis strains tested. These strains showed similar pathogenicity (ID
50) compared with four standard Gram-negative species.
(3) In streptozotocin-induced diabetic mice, ascending pyelonephritis occurred with 5 of 5
E. faecalis strains tested and values of ID
50 were 1/1.3-1/477 of those in non-treated mice.
(4) As to drug efficacy against experimental ascending pyelonephritis in non-treated mice, CPFX was most effective, followed by OFLX, MINO and ENX.
(5) Against experimental ascending pyelonephritis in streptozotocin-induced diabetic mice, ABPC was most effective, followed by CPFX, MINO and ENX; a longer administration period was necessary to eradicate
E. faecalis than in non-treated mice.
View full abstract